APTEKA "VERBENA" MARIA CICHOCKA-KORALEWSKA, WANDA WANOWSKA-FRĄCZEK SPÓŁKA JAWNA

TAX ID9551935725

KRS0000149542

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. BRĄZOWA 16, 70-781 SZCZECIN

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

APTEKA "VERBENA" MARIA CICHOCKA-KORALEWSKA, WANDA WANOWSKA-FRĄCZEK SPÓŁKA JAWNA

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. BRĄZOWA 16, 70-781 SZCZECIN

Show on map

NIP

9551935725

REGON

811877296

KRS

0000149542

Legal form

general partnership

Register Address

UL. BRĄZOWA 16, 70-781 SZCZECIN

Date of registration in KRS

2003-01-31

Date of commencement of economic activity

2003-01-31

Act signature

RDF/699455/25/705

Pkd codes

47.73.Z - Retail sale of pharmaceutical products

21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products

47.29.Z - Retail trade

47.74.Z - Retail sale of medical and orthopedic products

47.75.Z - Retail sale of cosmetics and toiletries

47.91.Z - Intermediary retail sale, non-specialized

68.10.Z - Real estate activities on own account and development of building projects

73.20.Z - Market research and public opinion polling

82.30.Z - Activities related to organizing fairs, exhibitions, and congresses

82.99.Z - Other business support activities, not elsewhere classified

Company authorities

representation authorityREPRESENTING THE COMPANY PARTNERS

representation type

WANDA JOANNA WANOWSKA-FRĄCZEK JEST UPRAWNIONA DO SAMODZIELNEJ REPREZENTACJI SPÓŁKI

REPRESENTING THE COMPANY PARTNERS

Wanda Joanna Wanowska Frączek

67 years old

shareholders

Maria Magdalena Cichocka Koralewska

Wanda Joanna Wanowska Frączek

Krzysztof Frączek

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2019	2020	2021
	M PLN	M PLN	M PLN	%
Gross profit (loss)	0,3	0,4	0,4	-8,5
EBITDA	0,4	0,4	0,4	-7
Short time liabilities	0,3	0,4	0,5	11
Equity capital	0,4	0,4	0,4	-8,4
Operating profit (EBIT)	0,3	0,4	0,4	-8,4
Assets	0,7	1	0,9	-8,3
Net profit (loss)	0,3	0,4	0,4	-8,5
Cash	0,3	0,4	0,4	-10,9
Net income from sale	4	4,3	4,3	1,1
Liabilities and provisions for liabilities	0,4	0,6	0,5	-8,2
Working assets	0,7	0,8	0,8	-5,6
Depreciation	0	0	0	10,4
	%	%	%	p.p.
Profitability of capital	98,6	98,8	98,7	-0,1
Equity capital to total assets	47,6	41,4	41,3	-0,1
Gross profit margin	8,7	9,4	8,5	-0,9
EBITDA Margin	9	10,2	9,4	-0,8
	Days	Days	Days	Days
Short term commitment turnover cycle	29	35	39	4

Current financial liquidity indicator	1.837561011314392	1.7837823629379272	1.5556156635284424	-0,2
Net dept to EBITDA	-0.8955678343772888	-0.7441148161888123	-0.8985835313796997	-0,2